Director/PDMR Shareholding

CVS

06/01/2026 09:34

RNS Number : 8185N

CVS Group plc

06 January 2026

 

6 January 2026

 

CVS Group plc

 

("CVS" or the "Company")

 

PDMR Dealing

CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 5 January 2026 that Richard Gray, Non-executive Director of the Company, purchased a total of 2,000 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.

As a result, Richard Gray's total interest in the Company, including all persons closely associated, is now at 9,600 Ordinary Shares, representing 0.014% per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc                                                                                                                               via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker)                                                                   +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

   Berenberg (Joint Broker)                                                                                                       +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR)                                                                                             

Ginny Pulbrook                                                                                                                         +44 (0)7961 315 138

   Letaba Rimell

   Tilly Butcher   

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Richard Gray
2
Reason for the notification
a)
Position/status
PDMR (Director)
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CVS Group plc
b)
LEI
213800J41XDQ2NX48O05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2 pence each
GB00B2863827
b)
Nature of the transaction
On-market purchase
c)
Price(s) and volume(s)
Price(s) - pence
Volume(s)
1,276.96
2,000
d)
Aggregated information
- Aggregated volume
- Price
N/A - single transaction
e)
Date of the transaction
5 January 2026
f)
Place of the transaction
London Stock Exchange - AIM (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHEANFKEDAKEEA